Eirini Lioudaki

873 total citations
31 papers, 362 citations indexed

About

Eirini Lioudaki is a scholar working on Nephrology, Endocrinology, Diabetes and Metabolism and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Eirini Lioudaki has authored 31 papers receiving a total of 362 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Nephrology, 10 papers in Endocrinology, Diabetes and Metabolism and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Eirini Lioudaki's work include Chronic Kidney Disease and Diabetes (6 papers), Potassium and Related Disorders (6 papers) and Diabetes Treatment and Management (5 papers). Eirini Lioudaki is often cited by papers focused on Chronic Kidney Disease and Diabetes (6 papers), Potassium and Related Disorders (6 papers) and Diabetes Treatment and Management (5 papers). Eirini Lioudaki collaborates with scholars based in United Kingdom, Greece and Italy. Eirini Lioudaki's co-authors include Emmanuel S. Ganotakis, Dimitri P. Mikhailidis, Emmanuel Androulakis, Kostas Stylianou, Dimitri P. Mikhailidis, Eugene Daphnis, Dimitris Tousoulis, Ioannis Petrakis, Martin Whyte and Νικόλαος Παπαγεωργίου and has published in prestigious journals such as American Journal of Kidney Diseases, Clinical Pharmacology & Therapeutics and Nephrology Dialysis Transplantation.

In The Last Decade

Eirini Lioudaki

30 papers receiving 358 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eirini Lioudaki United Kingdom 12 138 96 85 83 58 31 362
Doris Chan Australia 11 124 0.9× 142 1.5× 112 1.3× 100 1.2× 95 1.6× 30 439
Jennifer A. Schaub United States 12 100 0.7× 100 1.0× 155 1.8× 78 0.9× 57 1.0× 25 537
Sławomir Lizakowski Poland 12 73 0.5× 88 0.9× 117 1.4× 118 1.4× 73 1.3× 44 475
Ying Liao China 8 124 0.9× 49 0.5× 69 0.8× 115 1.4× 131 2.3× 21 323
Salvador Tranche Spain 16 85 0.6× 57 0.6× 113 1.3× 174 2.1× 44 0.8× 33 479
Soie Kwon South Korea 11 118 0.9× 86 0.9× 120 1.4× 34 0.4× 35 0.6× 37 392
Christopher C. Kaltenecker Austria 13 180 1.3× 227 2.4× 147 1.7× 160 1.9× 55 0.9× 21 643
Clara García-Carro Spain 12 157 1.1× 115 1.2× 148 1.7× 49 0.6× 40 0.7× 28 499
Sheila Bermejo Spain 13 81 0.6× 83 0.9× 158 1.9× 41 0.5× 32 0.6× 30 368
Yibo He China 14 113 0.8× 97 1.0× 210 2.5× 245 3.0× 115 2.0× 67 631

Countries citing papers authored by Eirini Lioudaki

Since Specialization
Citations

This map shows the geographic impact of Eirini Lioudaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eirini Lioudaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eirini Lioudaki more than expected).

Fields of papers citing papers by Eirini Lioudaki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eirini Lioudaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eirini Lioudaki. The network helps show where Eirini Lioudaki may publish in the future.

Co-authorship network of co-authors of Eirini Lioudaki

This figure shows the co-authorship network connecting the top 25 collaborators of Eirini Lioudaki. A scholar is included among the top collaborators of Eirini Lioudaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eirini Lioudaki. Eirini Lioudaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Androulakis, Emmanuel, Christos Kourek, Nikolaos Kontopodis, et al.. (2023). Assessment of extra-coronary peripheral arteriopathy in spontaneous coronary dissection: state of the art in non-invasive imaging techniques and future perspectives. PubMed. 1(2). qyad044–qyad044. 1 indexed citations
3.
Petrakis, Ioannis, et al.. (2023). Cardiorenal Syndrome: Challenges in Everyday Clinical Practice and Key Points towards a Better Management. Journal of Clinical Medicine. 12(12). 4121–4121. 6 indexed citations
4.
Roddick, Alistair, Alexa Wonnacott, David R. Webb, et al.. (2023). UK Kidney Association Clinical Practice Guideline: Sodium-Glucose Co-transporter-2 (SGLT-2) Inhibition in Adults with Kidney Disease 2023 UPDATE. BMC Nephrology. 24(1). 310–310. 37 indexed citations
5.
Somaschini, Alberto, Stefano Cornara, Andrea Demarchi, et al.. (2021). Extracorporeal veno-venous ultrafiltration in patients with acute heart failure. Reviews in Cardiovascular Medicine. 22(4). 1311–1322. 5 indexed citations
6.
Ster, Irina Chis, Alexander Sarnowski, Eirini Lioudaki, et al.. (2020). The Characteristics, Dynamics, and the Risk of Death in COVID-19 Positive Dialysis Patients in London, UK. Kidney360. 1(11). 1226–1243. 11 indexed citations
7.
8.
Fountoulakis, Nikolaos, Eirini Lioudaki, Eleftheria‐Kleio Dermitzaki, et al.. (2019). The P274S Mutation of Lecithin-Cholesterol Acyltransferase (LCAT) and Its Clinical Manifestations in a Large Kindred. American Journal of Kidney Diseases. 74(4). 510–522. 10 indexed citations
9.
Lioudaki, Eirini, et al.. (2017). Renal Effects of SGLT‐2 Inhibitors and Other Anti‐diabetic Drugs: Clinical Relevance and Potential Risks. Clinical Pharmacology & Therapeutics. 102(3). 470–480. 3 indexed citations
10.
Androulakis, Emmanuel, et al.. (2016). The Impact of Antiplatelet Treatment on Endothelial Function. Current Pharmaceutical Design. 22(29). 4512–4518. 6 indexed citations
11.
Lioudaki, Eirini, Kostas Stylianou, Ioannis Petrakis, et al.. (2015). Increased Urinary Excretion of Podocyte Markers in Normoalbuminuric Patients with Diabetes. ˜The œNephron journals/Nephron journals. 131(1). 34–42. 22 indexed citations
12.
Lioudaki, Eirini, Matilda Florentin, Emmanuel S. Ganotakis, & Dimitri P. Mikhailidis. (2013). Microalbuminuria: A Neglected Cardiovascular Risk Factor in Non-diabetic Individuals?. Current Pharmaceutical Design. 19(27). 4964–4980. 8 indexed citations
13.
Petrakis, Ioannis, Vasiliki Mavroeidi, Kostas Stylianou, et al.. (2013). Hsf-1 affects podocyte markers NPHS1, NPHS2 and WT1 in a transgenic mouse model of TTRVal30Met-related amyloidosis. Amyloid. 20(3). 164–172. 2 indexed citations
14.
Lioudaki, Eirini, et al.. (2013). Subclinical hypothyroidism and vascular risk: An update. HORMONES. 12(4). 495–506. 33 indexed citations
15.
Stylianou, Kostas, Ioannis Petrakis, Vasiliki Mavroeidi, et al.. (2012). Rapamycin induced ultrastructural and molecular alterations in glomerular podocytes in healthy mice. Nephrology Dialysis Transplantation. 27(8). 3141–3148. 8 indexed citations
16.
Stylianou, Kostas, et al.. (2011). Crescentic glomerulonephritis associated with vascular endothelial growth factor (VEGF) inhibitor and bisphosphonate administration. Nephrology Dialysis Transplantation. 26(5). 1742–1745. 16 indexed citations
17.
Lioudaki, Eirini, Emmanuel S. Ganotakis, & Dimitri P. Mikhailidis. (2011). Lipid Lowering Drugs and Gallstones: A Therapeutic Option?. Current Pharmaceutical Design. 17(33). 3622–3631. 16 indexed citations
18.
Lioudaki, Eirini, Emmanuel S. Ganotakis, & Dimitri P. Mikhailidis. (2011). Liver Enzymes: Potential Cardiovascular Risk Markers?. Current Pharmaceutical Design. 17(33). 3632–3643. 46 indexed citations
19.
Lioudaki, Eirini, Emmanuel S. Ganotakis, Dimitri P. Mikhailidis, & Devaki Nair. (2010). The Estrogenic Burden on Vascular Risk in Male-to-Female Transsexuals. Current Pharmaceutical Design. 16(34). 3815–3822. 9 indexed citations
20.
Lioudaki, Eirini, Emmanuel S. Ganotakis, & Dimitri P. Mikhailidis. (2010). Ezetimibe; More Than a Low Density Lipoprotein Cholesterol Lowering Drug? An Update After 4 Years. Current Vascular Pharmacology. 9(1). 62–86. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Doris Chan Breakdown of academic impact, for papers by Jennifer A. Schaub Breakdown of academic impact, for papers by Sławomir Lizakowski Breakdown of academic impact, for papers by Ying Liao Breakdown of academic impact, for papers by Salvador Tranche Breakdown of academic impact, for papers by Soie Kwon Breakdown of academic impact, for papers by Christopher C. Kaltenecker Breakdown of academic impact, for papers by Clara García-Carro Breakdown of academic impact, for papers by Sheila Bermejo Breakdown of academic impact, for papers by Yibo He
Rankless by CCL
2026